GE HealthCare Technologies Revenue 2020-2025 | GEHC
- GE HealthCare Technologies revenue for the quarter ending March 31, 2025 was $4.777B, a 2.73% increase year-over-year.
- GE HealthCare Technologies revenue for the twelve months ending March 31, 2025 was $19.799B, a 1.56% increase year-over-year.
- GE HealthCare Technologies annual revenue for 2024 was $19.672B, a 0.61% increase from 2023.
- GE HealthCare Technologies annual revenue for 2023 was $19.552B, a 6.6% increase from 2022.
- GE HealthCare Technologies annual revenue for 2022 was $18.341B, a 4.3% increase from 2021.
GE HealthCare Technologies Annual Revenue (Millions of US $) |
|
---|---|
2024 | $19,672 |
2023 | $19,552 |
2022 | $18,341 |
2021 | $17,585 |
2020 | $17,164 |
2019 | $16,633 |
GE HealthCare Technologies Quarterly Revenue (Millions of US $) |
|
---|---|
2025-03-31 | $4,777 |
2024-12-31 | $5,320 |
2024-09-30 | $4,863 |
2024-06-30 | $4,839 |
2024-03-31 | $4,650 |
2023-12-31 | $5,206 |
2023-09-30 | $4,822 |
2023-06-30 | $4,817 |
2023-03-31 | $4,707 |
2022-12-31 | $4,938 |
2022-09-30 | $4,576 |
2022-06-30 | $4,484 |
2022-03-31 | $4,343 |
2021-12-31 | |
2021-09-30 | |
2020-12-31 | |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $33.957B | $19.672B |
Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $216.470B | 25.39 |
Boston Scientific (BSX) | United States | $153.537B | 38.44 |
Stryker (SYK) | United States | $147.836B | 30.91 |
EssilorLuxottica (ESLOY) | France | $131.607B | 0.00 |
Medtronic (MDT) | Ireland | $115.044B | 16.31 |
Lonza Group Ag (LZAGY) | Switzerland | $49.188B | 0.00 |
Haleon (HLN) | United Kingdom | $42.812B | 24.44 |
ResMed (RMD) | United States | $38.280B | 28.75 |
Agilent Technologies (A) | United States | $31.827B | 20.75 |
Terumo (TRUMY) | Japan | $24.178B | 31.40 |
Koninklijke Philips (PHG) | Netherlands | $23.630B | 16.58 |
Insulet (PODD) | United States | $19.773B | 77.61 |
Zimmer Biomet Holdings (ZBH) | United States | $18.319B | 11.77 |
Baxter (BAX) | United States | $14.046B | 10.49 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.647B | 23.13 |
Lantheus Holdings (LNTH) | United States | $4.951B | 12.49 |
Prestige Consumer Healthcare (PBH) | United States | $3.734B | 16.68 |
Perrigo (PRGO) | Ireland | $3.704B | 9.39 |
Haemonetics (HAE) | United States | $3.544B | 16.14 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.300B | 27.42 |
ICU Medical (ICUI) | United States | $2.994B | 22.08 |
LeMaitre Vascular (LMAT) | United States | $1.803B | 40.31 |
QuidelOrtho (QDEL) | United States | $1.711B | 11.77 |
AtriCure (ATRC) | United States | $1.448B | 0.00 |
Acuren (TIC) | United States | $1.408B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.251B | 28.13 |
AdaptHealth (AHCO) | United States | $1.235B | 12.53 |
Phibro Animal Health (PAHC) | United States | $1.181B | 15.10 |
Neogen (NEOG) | United States | $1.037B | 13.28 |
BioLife Solutions (BLFS) | United States | $0.993B | 0.00 |
InMode (INMD) | Israel | $0.882B | 8.89 |
Kestra Medical Technologies (KMTS) | United States | $0.854B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.831B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.678B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
Owens & Minor (OMI) | United States | $0.598B | 4.96 |
Evolus (EOLS) | United States | $0.594B | 0.00 |
CeriBell (CBLL) | United States | $0.550B | 0.00 |
Valneva SE (VALN) | France | $0.540B | 0.00 |
ZimVie (ZIMV) | United States | $0.522B | 23.75 |
Surmodics (SRDX) | United States | $0.446B | 0.00 |
SNDL (SNDL) | Canada | $0.415B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.328B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.305B | 11.22 |
Cresco Labs (CRLBF) | United States | $0.302B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.264B | 78.33 |
Cerus (CERS) | United States | $0.264B | 0.00 |
Quanterix (QTRX) | United States | $0.259B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.256B | 21.57 |
OraSure Technologies (OSUR) | United States | $0.243B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
Brainsway (BWAY) | Israel | $0.228B | 60.45 |
Biote (BTMD) | United States | $0.219B | 6.17 |
Verano Holdings (VRNOF) | United States | $0.213B | 0.00 |
Omeros (OMER) | United States | $0.213B | 0.00 |
Organigram Global (OGI) | Canada | $0.196B | 0.00 |
High Tide (HITI) | Canada | $0.194B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.180B | 14.70 |
TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
Vireo Growth (VREOF) | United States | $0.151B | 0.00 |
Exagen (XGN) | United States | $0.148B | 0.00 |
FitLife Brands (FTLF) | United States | $0.122B | 14.99 |
TerrAscend (TSNDF) | Canada | $0.121B | 0.00 |
Jin Medical (ZJYL) | China | $0.101B | 0.00 |
Fonar (FONR) | United States | $0.099B | 12.82 |
MacroGenics (MGNX) | United States | $0.093B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.088B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.085B | 0.00 |
Apyx Medical (APYX) | United States | $0.085B | 0.00 |
Safety Shot (SHOT) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Zynex (ZYXI) | United States | $0.071B | 0.00 |
Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
Agape ATP (ATPC) | $0.065B | 0.00 | |
ImmuCell (ICCC) | United States | $0.062B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 14.87 |
Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
Nephros (NEPH) | United States | $0.038B | 51.00 |
Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |